Abiopharma

Nature Genetics Study Validates Seer’s Proteograph Platform as Essential for Turning Genetic Signals Into Reliable Drug Targets and Biomarkers

Fractyl Health to Participate in the 8th Annual Evercore Healthcare Conference

KALA BIO Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar

Karyopharm to Participate at the Piper Sandler 37th Annual Healthcare Conference

Cullinan Therapeutics Receives FDA Fast Track Designation for CLN-049, a Novel FLT3xCD3 T Cell Engager, in Relapsed/Refractory Acute Myeloid Leukemia

Akebia Announces Establishment of Rare Kidney Disease Pipeline

Bristol Myers Squibb - Bristol Myers Squibb Data at ASH 2025 Showcase Potential of Hematology Pipeline and Build Momentum for Next Generation Portfolio

Bristol Myers Squibb Data at ASH 2025 Showcase Potential of Hematology Pipeline and Build Momentum for Next Generation Portfolio

Bristol Myers Squibb Data at ASH 2025 Showcase Potential of Hematology Pipeline and Build Momentum for Next Generation Portfolio

ANI Pharmaceuticals Announces Board Transition